The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Neuroendocrine Tumors
Abstract
Neuroendocrine tumors affect cells throughout the nervous and endocrine systems that produce and secrete regulatory hormones. Common sites of origin include the endocrine pancreas; parathyroid, adrenal, and pituitary glands; calcitonin-producing cells of the thyroid (causing medullary thyroid carcinoma); and argentaffin cells of the gut (causing carcinoid tumors). Neuroendocrine tumors are rare and can be broadly subdivided into those with and those without a clinical syndrome. Most neuroendocrine tumors are malignant and metastasize commonly to lymph nodes and the liver or less commonly to bone, lung, brain, and other organs. Despite the widespread metastasis, these tumors are typically slow-growing and often have an insidious presentation. These guidelines discuss the diagnosis and management of neuroendocrine tumors and special considerations relating to these tumors; important updates include expanded information on octreotide use and a new algorithm on neuroendocrine tumors of unknown primary. For the most recent version of the guidelines, please visit NCCN.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, R. (1986) · Medical Entomology and Zoology · Cited by 8,752
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,149
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Fassnacht, M., Daffara, F., Tauchmanova, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 764
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
Rösch, T., Lightdale, C. J., Botet, J. F., Boyce, G. A., Sivak, M. V., Yasuda, K., Heyder, N., Palazzo, L., Dancygier, H., Schusdziarra, V., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262601 · Cited by 713
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M., & Mueller, P. R. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.1.9648789 · Cited by 693
Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT
Caoili, E. M., Korobkin, M., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., & Raghupathi, K. I. (2002) · Radiology · doi:10.1148/radiol.2223010766 · Cited by 690
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S., Jacobs, C., Mares, J. E., Landgraf, A. N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7858 · Cited by 649
Yao, J. C., Lombard-Bohas, C., Baudin, E., Kvols, L. K., Rougier, P., Ruszniewski, P., Hoosen, S., St. Peter, J., Haas, T., Lebwohl, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2669 · Cited by 647
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Kouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
Machens, A., Niccoli-Sire, P., Hoegel, J., Frank-Raue, K., van Vroonhoven, T. J., Roeher, H.-D., Wahl, R. A., Lamesch, P., Raue, F., Conte-Devolx, B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012915 · Cited by 545
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
Kulke, M. H., Stuart, K., Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Vincitore, M., Michelini, A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6046 · Cited by 513
Fynn, R. W. (1959) · PubMed · Cited by 502
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
Ekeblad, S., Sundin, A., Janson, E. T., Welin, S., Granberg, D., Kindmark, H., Dunder, K., Kozlovacki, G., Örlefors, H., Sigurd, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2053 · Cited by 473
Hepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Kennedy, A. S., Dezarn, W. A., McNeillie, P., Coldwell, D., Nutting, C., Carter, D., Murthy, R., Rose, S., Warner, R. R. P., Liu, D., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e4557 · Cited by 424
Yao, J. C., Phan, A., Hoff, P. M., Chen, H. X., Charnsangavej, C., Yeung, S.-C. J., Hess, K., Ng, C., Abbruzzese, J. L., & Ajani, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6374 · Cited by 414
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 387
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
Skinner, M. A., Moley, J. A., Dilley, W. G., Owzar, K., DeBenedetti, M. K., & Wells, S. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043999 · Cited by 381
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Shapiro, B., Copp, J., Sisson, J. C., Eyre, P., Wallis, J. W., & Beierwaltes, W. H. (1985) · PubMed · Cited by 344
Population-Based Study of Islet Cell Carcinoma
Yao, J. C., Eisner, M. P., Leary, C., Dagohoy, C., Phan, A., Rashid, A., Hassan, M., & Evans, D. B. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9566-6 · Cited by 338
Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment
NG, L., & LIBERTINO, J. M. (2003) · The Journal of Urology · doi:10.1097/00005392-200301000-00003 · Cited by 330
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
Duran, I., Kortmansky, J., Singh, D., Hirte, H., Kocha, W., Goss, G., Le, L., Oza, A., Nicklee, T., Ho, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603419 · Cited by 317
Berruti, A., Terzolo, M., Sperone, P., Pia, A., Della Casa, S., Gross, D. J., Carnaghi, C., Casali, P., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas
Moertel, C. G., Johnson, C. M., McKusick, M. A., Martin, J. K., Nagorney, D. M., Kvols, L. K., Rubin, J., & Kunselman, S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00008 · Cited by 292
Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium
Doppman, J. L., Chang, R., Fraker, D. L., Norton, J. A., Alexander, H. R., Miller, D. L., Collier, E., Skarulis, M. C., & Gorden, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00004 · Cited by 286
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
King, J., Quinn, R., Glenn, D. M., Janssen, J., Tong, D., Liaw, W., & Morris, D. L. (2008) · Cancer · doi:10.1002/cncr.23685 · Cited by 284
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
Siperstein, A. E., Rogers, S. J., Hansen, P. D., & Gitomirsky, A. (1997) · Surgery · doi:10.1016/s0039-6060(97)90221-x · Cited by 260
(2016) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/12798 · Cited by 255
Crucitti, F., Bellantone, R., Ferrante, A., Boscherini, M., & Crucitti, P. (1996) · Surgery · doi:10.1016/s0039-6060(96)80164-4 · Cited by 247
Bertagna, C., & Orth, D. N. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90384-3 · Cited by 245
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan, C. J., Lawton, G. P., Tang, L. H., West, A. B., & Modlin, I. M. (1995) · PubMed · Cited by 240
Rhee, T. K., Lewandowski, R. J., Liu, D. M., Mulcahy, M. F., Takahashi, G., Hansen, P. D., Benson, A. B., Kennedy, A. S., Omary, R. A., & Salem, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181728a45 · Cited by 233
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies
Reincke, M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.790 · Cited by 228
Gicquel, C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1444 · Cited by 224
Gicquel, C., Raffin-Sanson, M.-L., Gaston, V., Bertagna, X., Plouin, P.-F., Schlumberger, M., Louvel, A., Luton, J.-P., & Le Bouc, Y. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4170 · Cited by 213
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
Kaltsas, G., Rockall, A., Papadogias, D., Reznek, R., & Grossman, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510015 · Cited by 206
Plouin, P.-F., Duclos, J.-M., Soppelsa, F., Boublil, G., & Chatellier, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7392 · Cited by 201
Carcinoids of the rectum: An evaluation of 1271 reported cases
Soga, J. (1997) · Surgery Today · doi:10.1007/bf02385898 · Cited by 190
Khan, T. S., Imam, H., Juhlin, C., Skogseid, B., Gröndal, S., Tibblin, S., Wilander, E., Öberg, K., & Eriksson, B. (2000) · Annals of Oncology · doi:10.1023/a:1008377915129 · Cited by 183
Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma
Prys‐Roberts, C., & Farndon, J. R. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6667-z · Cited by 182
Ramanathan, R. K., Cnaan, A., Hahn, R. G., Carbone, P. P., & Haller, D. G. (2001) · Annals of Oncology · doi:10.1023/a:1011632713360 · Cited by 181
Parathyroid Autotransplantation in Primary Parathyroid Hyperplasia
Wells, S. A., Ellis, G. J., Gunnells, J. C., Schneider, A. B., & Sherwood, L. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197607082950201 · Cited by 181
The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors
Koch, C. A., Pacak, K., & Chrousos, G. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021069 · Cited by 177
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
Nehar, D., Lombard‐Bohas, C., Olivieri, S., Claustrat, B., Chayvialle, J., Penes, M., Sassolas, G., & Borson‐Chazot, F. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02030.x · Cited by 177
ISLET CELL TUMORS OF THE PANCREAS
Brentjens, R. J., & Saltz, L. B. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70141-9 · Cited by 173
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
MEN I pancreas: A histological and immunohistochemical study
Thompson, N. W., Lloyd, R. V., Nishiyama, R. H., Vinik, A. I., Strodel, W. E., Allo, M. D., Eckhauser, F. E., Talpos, G., & Mervak, T. (1984) · World Journal of Surgery · doi:10.1007/bf01654938 · Cited by 162
High‐dose 131I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma
Rose, B., Matthay, K. K., Price, D., Huberty, J., Klencke, B., Norton, J. A., & Fitzgerald, P. A. (2003) · Cancer · doi:10.1002/cncr.11518 · Cited by 158
Veytsman, I. G., Nieman, L. K., & Fojo, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2775 · Cited by 154
Insulin-Producing Islet Cell Tumors
Fajans, S. S., & Vinik, A. I. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30388-8 · Cited by 153
Experience in treatment of metastatic pulmonary carcinoid tumors
Granberg, D. O., Eriksson, B., Wilander, E., Grimfjärd, P., Fjällskog, M.-L., Öberg, K., & Skogseid, B. M. (2001) · Annals of Oncology · doi:10.1023/a:1012569909313 · Cited by 147
From incidentaloma to adrenocortical carcinoma: The surgical management of adrenal tumors
Shen, W. T., Sturgeon, C., & Duh, Q. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20180 · Cited by 144
p53 Mutations in sporadic adrenocortical tumors
Ohgaki, H., Kleihues, P., & Heitz, P. U. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540310 · Cited by 139
Molecular Markers and the Pathogenesis of Adrenocortical Cancer
Soon, P. S. H., McDonald, K. L., Robinson, B. G., & Sidhu, S. B. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0243 · Cited by 139
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry, L. J., Stuart, K. E., Stokes, K. R., & Clouse, M. E. (1994) · PubMed · Cited by 135
Kalinowski, M., Dreßler, M., König, A. O., El-Sheik, M., Rinke, A., Höffken, H., Gress, T. M., Arnold, R., Klose, K., & Wagner, H. (2009) · Digestion · doi:10.1159/000209849 · Cited by 126
Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer
Vassilopoulou‐Sellin, R., Klein, M. J., Schultz, P. N., Samaan, N. A., Guinee, V. F., Taylor, S. H., & Hess, K. R. (1993) · Cancer · doi:10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8 · Cited by 126
Carcinoid syndrome: a statistical evaluation of 748 reported cases.
Soga, J., Yakuwa, Y., & Osaka, M. (1999) · PubMed · Cited by 119
Hepatic Arterial Chemoembolization in the Management of Advanced Digestive Endocrine Tumors
Ruszniewski, P. B., & Malka, D. (2000) · Digestion · doi:10.1159/000051860 · Cited by 119
Chang, A., Glazer, H. S., Lee, J., Ling, D., & Heiken, J. P. (1987) · Radiology · doi:10.1148/radiology.163.1.3823423 · Cited by 108
Cooper, E. H. (1994) · The International Journal of Biological Markers · doi:10.1177/172460089400900401 · Cited by 101
Fazio, N., de Braud, F., Fave, G. D., & Öberg, K. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl144 · Cited by 95
Use ofm-[131I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., CARPENTIER, P., Fleury-Goyon, M. C., Gibold, C., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-455 · Cited by 91
Fjällskog, M.-L., Sundin, A., Westlin, J. E., Öberg, K., Janson, E. T., & Eriksson, B. K. (2002) · Medical Oncology · doi:10.1385/mo:19:1:35 · Cited by 80
Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography
Schultz, C. L., Haaga, Fletcher, B. D., Alfidi, R. J., & Ma, S. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.143.6.1235 · Cited by 79
Dickstein, G., Shechner, C., Arad, E., Best, L., & Nativ, O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5113 · Cited by 74
Stehouwer, C. D. A., Lems, W. F., Fischer, H. R. A., Hackeng, W. H. L., & Naafs, M. A. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210034 · Cited by 73
Laparoscopic adrenalectomy for malignant disease
Saunders, B., & Doherty, G. M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01647-x · Cited by 72
Murthy, R., Kamat, P. P., NUÑEZ, R. F., Madoff, D. C., Gupta, S. K., Salem, R., & Yao, J. C. (2008) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2007.09.006 · Cited by 69
Adrenocortical Carcinoma: Surgery and Mitotane for Treatment and Steroid Profiles for Follow‐up
Khorram‐Manesh, A., Ahlman, H., Jansson, S., Wängberg, B., Nilsson, O., Jakobsson, C. E., Eliasson, B., Lindstedt, S., & Tisell, L. E. (1998) · World Journal of Surgery · doi:10.1007/s002689900442 · Cited by 65
Solcia, E., Rindi, G., Paolotti, D., Rosa, S. L., Capella, C., & Fiocca, R. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s9 · Cited by 62
Management of Pancreatic Endocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1
Thompson, N. W. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30250-3 · Cited by 61
Effective treatment of neuroendocrine tumors With temozolomide and capecitabine
Fine, R. L., Fogelman, D. R., & Schreibman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.4216 · Cited by 60
Chromogranin A as a determinant of midgut carcinoid tumour volume
Kölby, L., Bernhardt, P., Swärd, C., Johanson, V., Ahlman, H., Forssell-Aronsson, E. B., Stridsberg, M., Wängberg, B., & Nilsson, O. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.017 · Cited by 58
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
BERNINI, G. P., Moretti, A., Ferdeghini, M., Ricci, S., Letizia, C., D'Erasmo, E., Argenio, G. F., & Salvetti, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1659 · Cited by 56
Cardiac manifestations in mid-gut carcinoid disease
Jacobsen, M. B., NITTER‐HAUGE, S., Bryde, P., & Hanssen, L. E. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060894 · Cited by 44
Kwekkeboom, D. J., Teunissen, J. J. M., Kam, B. L. R., Valkema, R., de Herder, W. W., & Krenning, E. P. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.009 · Cited by 35
Lynch, H. T., Radford, B., & Lynch, J. F. (2009) · Oncology · doi:10.1159/000226789 · Cited by 28
Update on the treatment of neuroendocrine tumors
Bajetta, E., Procopio, G., Ferrari, L., Catena, L., Vecchio, M. D., & Bombardieri, E. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.5.631 · Cited by 27
Wooten (1993) · doi:10.1002/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n
Cited by
Deprez, P. H., Moons, L. M. G., OʼToole, D., Gincul, R., Seicean, A., Pimentel-Nunes, P., Fernández-Esparrach, G., Polkowski, M., Vieth, M., Borbath, I., et al. (2022) · Endoscopy · doi:10.1055/a-1751-5742 · Cited by 384
Somatostatin Analogs in Clinical Practice: A Review
Gomes-Porras, M., Cárdenas-Salas, J., & Álvarez-Escolá, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051682 · Cited by 264
Metadata
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2009-07
- Volume
- 7
- Issue
- 7
- Pages
- 712-712
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2415429194
- Cited by
- 292
- References
- 97
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.